New MRI Technique Successfully Separates Overlapping Metabolite Signals in Genetic Metabolic Disorder
Researchers have developed a Hadamard-encoded magnetic resonance spectroscopy (MRS) technique capable of separately detecting methylmalonic acid (MMA) and lactate in the brain at 3 Tesla, overcoming a longstanding signal overlap problem. Methylmalonic acidemia is a rare genetic disorder in which MMA accumulates and causes impaired energy metabolism, but its MRS signal at 1.23 ppm has historically been indistinguishable from lactate at 1.33 ppm using conventional methods. The new approach could improve both the understanding of disease mechanisms and the monitoring of treatment responses in affected patients.
Methylmalonic acidemia (MMAemia) is a rare inherited metabolic disorder marked by toxic accumulation of methylmalonic acid and elevated lactate due to impaired energy metabolism. A key diagnostic and research challenge has been that the MRS signals of MMA (1.23 ppm) and lactate (1.33 ppm) overlap substantially, preventing conventional spectroscopy from distinguishing them. The newly developed method uses a four-step Hadamard-encoded J-difference editing scheme with frequency-selective pulses applied at 3.2 ppm and 4.1 ppm to selectively modulate the J-coupled methyl resonances of MMA and lactate, respectively. Combining the four sub-experiments via Hadamard mathematics yields separate edited spectra for each metabolite. The technique was validated through density-matrix simulations, phantom experiments, and in vivo scans: a healthy infant showed only a lactate signal, while a patient with MMAemia showed both lactate and MMA cleanly separated into their respective spectra. The study was conducted at 3 Tesla, a widely available clinical field strength, suggesting potential for broader clinical adoption. The authors conclude the method shows promise for studying altered metabolism and improving treatment monitoring in MMAemia patients.
What's missing
The study reports only a single patient case for in vivo validation of MMA detection, leaving questions about sensitivity, reproducibility, and performance across a larger patient cohort unaddressed. Long-term clinical utility and whether separated MMA quantification correlates meaningfully with disease severity or treatment outcomes remain open questions.
What different sources said
- bioRxivCenter
Individualised mapping of living human brain mitochondria by MRI reveals signatures of bioenergetic defects.
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.